Biden details efforts to end cancer on anniversary of famous 'Moonshot' speech
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
President Biden delivered his "Cancer Moonshot" address in the John F. Kennedy Presidential Library and Museum in Boston on Monday, discussing his goal of cutting the U.S. cancer death rate in half over the next quarter-century. This speech comes on the 60th anniversary of Kennedy's famous "moonshot speech" about his goal of putting a man on the moon.
In his speech, Biden announced Dr. Renee Wegrzyn as the inaugural Director of Advanced Research Projects Agency for Health (ARPA-H), a new agency created to drive biomedical innovation. He also signed an executive order to launch a National Biotechnology and Biomanufacturing Initiative, an initiative to grow the strength and diversity of domestic biomanufacturing capacity. Biden also emphasized his efforts to lower prescription drug costs, including cancer drugs, through the Inflation Reduction Act of 2022.
The Cancer Moonshot was originally launched when Biden was vice president under the Obama administration. He relaunched the initiative in Feb. 2022 as president. It has been an initiative that the president has personally been invested in, especially after losing his son, Beau Biden to an aggressive form of brain cancer in 2015.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Cancer does not discriminate," Biden said. "Beating cancer is something we can do together."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
Crisis in Cuba: a ‘golden opportunity’ for Washington?Talking Point The Trump administration is applying the pressure, and with Latin America swinging to the right, Havana is becoming more ‘politically isolated’
-
5 thoroughly redacted cartoons about Pam Bondi protecting predatorsCartoons Artists take on the real victim, types of protection, and more
-
Palestine Action and the trouble with defining terrorismIn the Spotlight The issues with proscribing the group ‘became apparent as soon as the police began putting it into practice’
-
Sepsis ‘breakthrough’: the world’s first targeted treatment?The Explainer New drug could reverse effects of sepsis, rather than trying to treat infection with antibiotics
-
Scientists are worried about amoebasUnder the radar Small and very mighty
-
Metal-based compounds may be the future of antibioticsUnder the radar Robots can help develop them
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
Stopping GLP-1s raises complicated questions for pregnancyThe Explainer Stopping the medication could be risky during pregnancy, but there is more to the story to be uncovered
-
Tips for surviving loneliness during the holiday season — with or without peoplethe week recommends Solitude is different from loneliness
-
More women are using more testosterone despite limited researchThe explainer There is no FDA-approved testosterone product for women
-
Peanut allergies have plummeted in childrenUnder the radar Early introduction could be an effective prevention method
